• (S)-Mephenytoin in Intestinal Organoid Assays

  2026-08-31

  Discover how (S)-Mephenytoin can function as a CYP2C19 substrate probe in human iPSC-derived intestinal organoid workflows. This guide focuses on assay architecture, metabolite interpretation, and the practical limits of translating organoid CYP activity into pharmacokinetic evidence.

• Cefepime (BMY-28142) in Viability Assays

  2026-08-30

  Learn how Cefepime (BMY-28142), SKU BA1013, can be integrated into bacterial infection models without confusing antimicrobial effects with host-cell viability. This scenario-based guide covers assay compatibility, fresh-solution handling, interpretation, and practical product selection.

• Ceftolozane/Tazobactam: Innovation and Evidence

  2026-08-29

  This review evaluates ceftolozane/tazobactam as an antipseudomonal cephalosporin and beta-lactamase inhibitor combination designed to address resistant gram-negative infections. Its key contribution is the integration of mechanism, resistance activity, pharmacokinetics, pharmacodynamics, clinical trial evidence, and safety data into a framework for interpreting its use in complicated intraabdominal and urinary tract infections.

• Sodium Citrate for Reproducible SERS Assays

  2026-08-29

  Sodium citrate can provide a controllable chemical environment for SERS assay development, but its effects on plasmonic assembly must be separated from the geometry of the substrate. This article translates a 3D gold nanocluster study into a practical framework for buffer, chelation, protein-matrix, and reproducibility decisions.

• THBS1 in Laryngeal Cancer: Evidence and Methods

  2026-08-28

  The reference study combines transcriptomic cohorts, machine-learning feature selection, immune-pathway analysis, and cell-based assays to identify THBS1 as a prognostic and functionally relevant factor in laryngeal cancer. Its results connect THBS1 with epithelial-to-mesenchymal transition, integrin signaling, lipid metabolism, immune suppression, and a possible clopidogrel-related therapeutic vulnerability, while highlighting the need for clinical validation.

• NF 449: Selective Purinergic Receptor Antagonist

  2026-08-28

  NF 449 is a receptor subtype-selective tool for separating ATP-driven P2X1 signaling from P2Y1 and P2Y12 responses in platelet experiments. This guide translates its receptor pharmacology into practical workflows for platelet activation studies, collagen assays, thrombosis models, and troubleshooting.

• AG-126: A Decision Framework for ERK Studies

  2026-08-27

  AG-126 and Tyrphostin AG-126 provide a focused way to test whether ERK1/2 signaling contributes to inflammation and striatal circuit phenotypes. This article presents an evidence-calibrated assay framework that separates ERK causality from PKC-driven neuronal mechanisms.

• HotStart 2X Green qPCR Master Mix: Workflow Guide

  2026-08-27

  Build reproducible SYBR Green assays for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification with a streamlined hot-start workflow. The guide translates targeted mRNA nanovaccine findings into practical qPCR readouts while addressing specificity, controls, and melt-curve troubleshooting.

• Ertapenem Sodium Salt in Resistance Workflows

  2026-08-26

  Ertapenem sodium salt supports reproducible MIC, time-kill, and resistance-transfer experiments without forcing researchers to treat phenotype as a substitute for genotype. This workflow-focused guide connects carbapenem exposure assays with plasmid localization, conjugation, PCR, and troubleshooting strategies for antibiotic resistance research.

• WAY-100635 in 5-HT1A Assay Workflows

  2026-08-26

  Use WAY-100635 to separate 5-HT1A receptor signaling from agonist-driven behavioral, pain, and neuronal effects. This guide connects binding assays, functional pharmacology, behavioral controls, and imaging-oriented workflows while highlighting practical troubleshooting.

• Sodium Dicloxacillin Monohydrate: Translational Strategy

  2026-08-25

  A mechanistic and translational guide to using sodium dicloxacillin monohydrate for MSSA research, integrating PBP inhibition, intracellular activity, PK/PD design, pH effects, and drug–drug interaction considerations.

• 4-Ethylphenyl Sulfate: From Toxin to Translation

  2026-08-25

  4-Ethylphenyl sulfate is more than a catalog analyte: it offers a translational bridge between microbiota-derived chemistry, renal dysfunction, neurobehavioral phenotypes, and disease-conditioned biomaterial performance. This article outlines how researchers can build rigorous assays around 4-ethylphenyl hydrogen sulfate while avoiding overinterpretation of biomarker and causal evidence.

• SIRT1–PGC-1α/TFAM Signaling in Prion Toxicity

  2026-08-24

  Zhao et al. identify a mechanistic pathway in which reduced SIRT1 activity contributes to PrP106–126-induced mitochondrial injury in N2a neuroblastoma cells. The study shows that SIRT1 enhancement, including resveratrol treatment, supports PGC-1α–TFAM-mediated mitochondrial biogenesis, improves mitochondrial integrity, and reduces apoptosis.

• Bradykinin BA5201: Practical Research Workflow

  2026-08-23

  Bradykinin BA5201 provides a defined research peptide for studying endothelium-dependent vasodilation, vascular permeability modulation, smooth muscle contraction, pain mechanisms, and inflammation signaling. It is intended for controlled laboratory experiments only; the dossier does not establish clinical use, diagnostic utility, or a universal concentration and exposure protocol.

• Uridine, Trisodium Salt in Reliable Cell Assays

  2026-08-22

  Learn how Uridine, Trisodium Salt (SKU B1473) can support controlled RNA biosynthesis, RNA metabolism studies, and mechanistic interpretation of cell-based viability or proliferation experiments. This scenario-driven guide covers compatibility, preparation, data interpretation, and practical reagent selection using documented purity, solubility, and quality-control information.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page